首页 > 最新文献

INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE最新文献

英文 中文
Knowledge of community pharmacists in the Kathmandu Valley, Nepal about the risks associated with medication use during pregnancy. 尼泊尔加德满都谷地社区药剂师对怀孕期间用药风险的了解。
IF 1.7 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.3233/JRS-210026
Sajala Kafle, Nisha Jha, Yunima Sapkota, Pathiyil Ravi Shankar

Background: Community pharmacists are among the most accessible health care providers.

Objective: This study evaluates the knowledge of community pharmacists about the risks associated with medication use during pregnancy.

Methods: A cross-sectional study was carried out in March 2021 among the 344 community pharmacies in the Kathmandu Valley, Nepal. Convenience sampling was used for data collection using a structured and validated questionnaire.

Results: The majority of participants were male: 264 (76.7%), 94.2% were between the age of 21 to 30 years, and 53.1% had work experience of less than one year. Over half had completed diploma in pharmacy. Less than 10 medicines were dispensed to pregnant women daily in 61.6% of the pharmacies. Only 28.8% of the community pharmacists always inquired about pregnancy status from women in the reproductive age group. The median knowledge score was significantly different among individuals with different work experience and qualifications (p < 0.001). There was also difference in median scores according to average number of medicines dispensed daily (p = 0.006). The knowledge score also differed according to average number of medicines dispensed to pregnant woman and inquiry by the pharmacist about pregnancy status (p < 0.001).

Conclusion: Our study revealed that the median knowledge scores need improvement.

背景:社区药剂师是最容易获得的卫生保健提供者之一。目的:了解社区药师对妊娠期用药风险的了解情况。方法:于2021年3月对尼泊尔加德满都谷地的344家社区药店进行横断面研究。数据收集采用方便抽样,采用结构化和有效的问卷。结果:调查对象以男性为主,264人(76.7%),年龄在21 ~ 30岁之间的占94.2%,工作经验不足1年的占53.1%。超过一半的学生已完成药剂学文凭。61.6%的药房每天给孕妇配药不足10种。仅有28.8%的社区药师经常向育龄妇女询问妊娠情况。不同工作经验和学历的个体知识得分中位数差异有统计学意义(p < 0.001)。根据平均每日配药次数,中位评分也有差异(p = 0.006)。平均给孕妇配药次数和药师询问妊娠状况的知识得分也存在差异(p < 0.001)。结论:我们的研究显示知识得分中位数需要提高。
{"title":"Knowledge of community pharmacists in the Kathmandu Valley, Nepal about the risks associated with medication use during pregnancy.","authors":"Sajala Kafle,&nbsp;Nisha Jha,&nbsp;Yunima Sapkota,&nbsp;Pathiyil Ravi Shankar","doi":"10.3233/JRS-210026","DOIUrl":"https://doi.org/10.3233/JRS-210026","url":null,"abstract":"<p><strong>Background: </strong>Community pharmacists are among the most accessible health care providers.</p><p><strong>Objective: </strong>This study evaluates the knowledge of community pharmacists about the risks associated with medication use during pregnancy.</p><p><strong>Methods: </strong>A cross-sectional study was carried out in March 2021 among the 344 community pharmacies in the Kathmandu Valley, Nepal. Convenience sampling was used for data collection using a structured and validated questionnaire.</p><p><strong>Results: </strong>The majority of participants were male: 264 (76.7%), 94.2% were between the age of 21 to 30 years, and 53.1% had work experience of less than one year. Over half had completed diploma in pharmacy. Less than 10 medicines were dispensed to pregnant women daily in 61.6% of the pharmacies. Only 28.8% of the community pharmacists always inquired about pregnancy status from women in the reproductive age group. The median knowledge score was significantly different among individuals with different work experience and qualifications (p < 0.001). There was also difference in median scores according to average number of medicines dispensed daily (p = 0.006). The knowledge score also differed according to average number of medicines dispensed to pregnant woman and inquiry by the pharmacist about pregnancy status (p < 0.001).</p><p><strong>Conclusion: </strong>Our study revealed that the median knowledge scores need improvement.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39830629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and persistence of patient-reported visual problems associated with serotonin reuptake inhibiting antidepressants. 患者报告的与血清素再摄取抑制抗抑郁药相关的视力问题的发展和持续。
IF 1.7 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.3233/JRS-210018
David Healy, Dee Mangin, Jonathan Lochhead

Background: The majority of antidepressants inhibit serotonin reuptake and include the selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and the serotonin reuptake inhibiting tricyclic antidepressants.

Objective: The objective of this study was to investigate and describe the range and impact of reported adverse visual effects linked to serotonin reuptake inhibiting antidepressants.

Methods: Using data from a global database of patient spontaneous reports of drug adverse events, we systematically identified eligible reports of visual problems linked to the use of serotonin reuptake inhibiting antidepressants. We analyzed these data using simple descriptive statistics to present the range and impact.

Results: We identified 124 reports of visual problems. Reports originate from 18 countries and involve 11 different drugs. The most commonly reported symptoms were vision blurred/visual acuity reduced (n = 79, 63.7%), night blindness (n = 22, 17.7%), vitreous floaters (n = 21, 16.9%), photophobia (n = 19, 15.3%), diplopia (n = 15, 12.1%), palinopsia (n = 13, 10.5%), visual field defect (n = 12, 9.7%), photopsia (n = 11, 8.9%) and visual snow syndrome (n = 11, 8.9%). 74 patients indicated that the side effect was bad enough to affect everyday activities, 62 had sought health care, and 50 indicated that their work had been affected. 49 patients reported an enduring vision problem after discontinuation of treatment.

Conclusions: The data suggest that serotonin reuptake inhibiting antidepressants can produce a range of adverse effects on vision that in some cases can be long-lasting after discontinuation of the drug. Further efforts are needed to understand the mechanisms involved, the incidence among those prescribed these medications, and identify any risk or mitigation factors.

背景:大多数抗抑郁药抑制5 -羟色胺再摄取,包括选择性5 -羟色胺再摄取抑制剂(SSRIs)、5 -羟色胺-去甲肾上腺素再摄取抑制剂(SNRIs)和抑制5 -羟色胺再摄取的三环抗抑郁药。目的:本研究的目的是调查和描述报道的与血清素再摄取抑制抗抑郁药相关的不良视觉效果的范围和影响。方法:使用来自全球患者自发报告药物不良事件数据库的数据,我们系统地确定了与使用5 -羟色胺再摄取抑制抗抑郁药相关的视力问题的合格报告。我们使用简单的描述性统计来分析这些数据,以显示范围和影响。结果:我们确定了124例视力问题报告。报告来自18个国家,涉及11种不同的药物。最常见的症状为视力模糊/视力下降(n = 79, 63.7%)、夜盲症(n = 22, 17.7%)、玻璃体飞蚊症(n = 21, 16.9%)、畏光(n = 19, 15.3%)、复视(n = 15, 12.1%)、回视(n = 13, 10.5%)、视野缺损(n = 12, 9.7%)、失光(n = 11, 8.9%)和视觉雪综合征(n = 11, 8.9%)。74名患者表示,副作用严重到足以影响日常活动,62名患者寻求医疗保健,50名患者表示他们的工作受到影响。49例患者在停止治疗后出现持久的视力问题。结论:数据表明,抑制5 -羟色胺再摄取的抗抑郁药会对视力产生一系列不良影响,在某些情况下,这些不良影响在停药后会持续很长时间。需要进一步努力了解所涉及的机制,这些药物在处方者中的发病率,并确定任何风险或缓解因素。
{"title":"Development and persistence of patient-reported visual problems associated with serotonin reuptake inhibiting antidepressants.","authors":"David Healy,&nbsp;Dee Mangin,&nbsp;Jonathan Lochhead","doi":"10.3233/JRS-210018","DOIUrl":"https://doi.org/10.3233/JRS-210018","url":null,"abstract":"<p><strong>Background: </strong>The majority of antidepressants inhibit serotonin reuptake and include the selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and the serotonin reuptake inhibiting tricyclic antidepressants.</p><p><strong>Objective: </strong>The objective of this study was to investigate and describe the range and impact of reported adverse visual effects linked to serotonin reuptake inhibiting antidepressants.</p><p><strong>Methods: </strong>Using data from a global database of patient spontaneous reports of drug adverse events, we systematically identified eligible reports of visual problems linked to the use of serotonin reuptake inhibiting antidepressants. We analyzed these data using simple descriptive statistics to present the range and impact.</p><p><strong>Results: </strong>We identified 124 reports of visual problems. Reports originate from 18 countries and involve 11 different drugs. The most commonly reported symptoms were vision blurred/visual acuity reduced (n = 79, 63.7%), night blindness (n = 22, 17.7%), vitreous floaters (n = 21, 16.9%), photophobia (n = 19, 15.3%), diplopia (n = 15, 12.1%), palinopsia (n = 13, 10.5%), visual field defect (n = 12, 9.7%), photopsia (n = 11, 8.9%) and visual snow syndrome (n = 11, 8.9%). 74 patients indicated that the side effect was bad enough to affect everyday activities, 62 had sought health care, and 50 indicated that their work had been affected. 49 patients reported an enduring vision problem after discontinuation of treatment.</p><p><strong>Conclusions: </strong>The data suggest that serotonin reuptake inhibiting antidepressants can produce a range of adverse effects on vision that in some cases can be long-lasting after discontinuation of the drug. Further efforts are needed to understand the mechanisms involved, the incidence among those prescribed these medications, and identify any risk or mitigation factors.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/JRS-210018","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39290026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Patients' perception of personal protective equipment during the SARS-Cov-2 pandemic. SARS-Cov-2大流行期间患者对个人防护装备的认知
IF 1.7 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.3233/JRS-227032
Aly Zaheer Pathan, Jennifer Barwell, Artemis Kastrissianakis, Kiran Awan, Anie Abila, Amelia Lim, Rucchira Wickramasinghe, Anuj Pathare, Susan Deakin

Background: Since the outbreak of the coronavirus (SARS-Cov-2), wearing personal protective equipment (PPE) has become necessary. Patients' ability to recognize staff is disrupted impacting on the relationship between healthcare worker and patient.

Objective: Assess the patients' perspective of healthcare workers wearing PPE and its effect on communication.

Methods: Admitted Orthopaedic patients during the first wave of SARS-Cov-2 were surveyed about the experience with staff wearing PPE. In response to feedback, individual badges with large pictures and names were introduced to wear over PPE. Patient views and response to the badges was collected from surveying admitted patients.

Results: Patients encountered staff wearing face masks and felt this was appropriate in the context of the pandemic. 44% responded that they would prefer staff wearing badges with names, roles and pictures more visible. Following the introduction of badges, patients were better able to recognize staff roles and remember names. Hospital staff felt this was a positive change to help improve rapport while wearing PPE.

Conclusion: Wearing PPE affects patients' ability to recognize individuals in a fast-paced environment such as an acute hospital. Introducing badges was an intervention based on patient feedback and an important adaptation to sustained PPE use to improve the patient's experience.

背景:自冠状病毒(SARS-Cov-2)爆发以来,穿戴个人防护装备(PPE)已成为必要。患者识别工作人员的能力受到干扰,影响医护人员与患者之间的关系。目的:评价医务人员佩戴个人防护装备的患者观点及其对沟通的影响。方法:对第一波SARS-Cov-2期间收治的骨科患者进行调查,了解工作人员佩戴个人防护装备的经历。根据反馈意见,我们引入了带有大图和名字的个人徽章,佩戴在PPE上。患者对徽章的看法和反应是通过调查住院患者收集的。结果:患者遇到戴口罩的工作人员,并认为这在大流行的背景下是合适的。44%的受访者表示,他们更希望员工佩戴带有姓名、角色和照片的徽章。在引入徽章之后,患者能够更好地识别工作人员的角色并记住他们的名字。医院工作人员认为这是一个积极的变化,有助于改善佩戴个人防护装备时的融洽关系。结论:在急症医院等快节奏环境中,佩戴个人防护装备会影响患者识别个体的能力。引入徽章是一种基于患者反馈的干预措施,也是对持续使用个人防护装备以改善患者体验的重要适应。
{"title":"Patients' perception of personal protective equipment during the SARS-Cov-2 pandemic.","authors":"Aly Zaheer Pathan,&nbsp;Jennifer Barwell,&nbsp;Artemis Kastrissianakis,&nbsp;Kiran Awan,&nbsp;Anie Abila,&nbsp;Amelia Lim,&nbsp;Rucchira Wickramasinghe,&nbsp;Anuj Pathare,&nbsp;Susan Deakin","doi":"10.3233/JRS-227032","DOIUrl":"https://doi.org/10.3233/JRS-227032","url":null,"abstract":"<p><strong>Background: </strong>Since the outbreak of the coronavirus (SARS-Cov-2), wearing personal protective equipment (PPE) has become necessary. Patients' ability to recognize staff is disrupted impacting on the relationship between healthcare worker and patient.</p><p><strong>Objective: </strong>Assess the patients' perspective of healthcare workers wearing PPE and its effect on communication.</p><p><strong>Methods: </strong>Admitted Orthopaedic patients during the first wave of SARS-Cov-2 were surveyed about the experience with staff wearing PPE. In response to feedback, individual badges with large pictures and names were introduced to wear over PPE. Patient views and response to the badges was collected from surveying admitted patients.</p><p><strong>Results: </strong>Patients encountered staff wearing face masks and felt this was appropriate in the context of the pandemic. 44% responded that they would prefer staff wearing badges with names, roles and pictures more visible. Following the introduction of badges, patients were better able to recognize staff roles and remember names. Hospital staff felt this was a positive change to help improve rapport while wearing PPE.</p><p><strong>Conclusion: </strong>Wearing PPE affects patients' ability to recognize individuals in a fast-paced environment such as an acute hospital. Introducing badges was an intervention based on patient feedback and an important adaptation to sustained PPE use to improve the patient's experience.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/94/51/jrs-33-jrs227032.PMC9844063.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10782286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers to access to clinical trial data: Obstruction of a RIAT reanalysis of the treatment for adolescents with depression study. 获取临床试验数据的障碍:阻碍了青少年抑郁症治疗的RIAT再分析研究。
IF 1.7 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.3233/JRS-210022
Natalie Aboustate, Jon Jureidini

Background: Public access to data has been a major step in attempting to reduce bias in scientific literature. Data to verify efficacy outcomes are now more accessible; however, little has been done to ensure public access to harms data from RCTs, which are equally important in ascertaining possible misreporting and protecting safety.

Objective: The treatment for adolescents with depression study (TADS) has influenced most international practice guidelines for treating children and adolescents with depression, supporting first-line prescription of fluoxetine in combination with cognitive behavioural therapy (CBT). However, after over 30 publications by the TADS team, reporting on harms remains highly deficient and we aimed to redress this lack.

Methods: In undertaking a restoring invisible and abandoned trials (RIAT) reanalysis of TADS' effectiveness and safety outcomes, we sought access to de-identified serious adverse events (SAE) data.

Results: This paper describes our unsuccessful efforts to obtain more detailed SAE data from TADS' data custodians, highlighting several problematic blocks to comprehensive safety reporting.

Conclusion: Comprehensive access to clinical trial data is necessary to ensure safe and fully informed guidelines for treating children and adolescents with depression.

背景:公众获取数据是试图减少科学文献偏见的重要一步。验证疗效结果的数据现在更容易获得;然而,在确保公众获得随机对照试验的危害数据方面做得很少,这些数据在确定可能的误报和保护安全方面同样重要。目的:青少年抑郁症治疗研究(TADS)影响了大多数治疗儿童和青少年抑郁症的国际实践指南,支持氟西汀联合认知行为疗法(CBT)的一线处方。然而,在TADS团队发表了30多篇论文之后,对危害的报道仍然非常不足,我们的目标是弥补这一不足。方法:在对TADS的有效性和安全性进行恢复不可见和放弃试验(RIAT)再分析时,我们寻求获得未识别的严重不良事件(SAE)数据。结果:本文描述了我们从TADS的数据保管人那里获得更详细的SAE数据的失败努力,强调了全面安全报告的几个问题。结论:全面获得临床试验数据是必要的,以确保安全和充分知情的指导方针治疗儿童和青少年抑郁症。
{"title":"Barriers to access to clinical trial data: Obstruction of a RIAT reanalysis of the treatment for adolescents with depression study.","authors":"Natalie Aboustate,&nbsp;Jon Jureidini","doi":"10.3233/JRS-210022","DOIUrl":"https://doi.org/10.3233/JRS-210022","url":null,"abstract":"<p><strong>Background: </strong>Public access to data has been a major step in attempting to reduce bias in scientific literature. Data to verify efficacy outcomes are now more accessible; however, little has been done to ensure public access to harms data from RCTs, which are equally important in ascertaining possible misreporting and protecting safety.</p><p><strong>Objective: </strong>The treatment for adolescents with depression study (TADS) has influenced most international practice guidelines for treating children and adolescents with depression, supporting first-line prescription of fluoxetine in combination with cognitive behavioural therapy (CBT). However, after over 30 publications by the TADS team, reporting on harms remains highly deficient and we aimed to redress this lack.</p><p><strong>Methods: </strong>In undertaking a restoring invisible and abandoned trials (RIAT) reanalysis of TADS' effectiveness and safety outcomes, we sought access to de-identified serious adverse events (SAE) data.</p><p><strong>Results: </strong>This paper describes our unsuccessful efforts to obtain more detailed SAE data from TADS' data custodians, highlighting several problematic blocks to comprehensive safety reporting.</p><p><strong>Conclusion: </strong>Comprehensive access to clinical trial data is necessary to ensure safe and fully informed guidelines for treating children and adolescents with depression.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39830626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Considerations on the sidelines of the second principle of the Rome Declaration: The challenge of the One Health concept on the health of the future. 《罗马宣言》第二项原则的附带考虑:同一个健康概念对未来健康的挑战。
IF 1.7 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.3233/JRS-227003
Tommaso Di Paolo

Background: The COVID-19 pandemic represented a global earthquake that made the review of health policies aimed at strengthening common governance necessary.

Objective: The paper analyses the reasons for which the One Health approach has become fundamental in the control of pandemic phenomena, by arguing the necessity to place it at the basis not only of health policies but also of intersectoral policies.

Methods: The documents of the world organizations published before and after the pandemic were analyzed and studied in order to unpack the close relationship between new lifestyles and the increase of health risks.

Results: It emerged that the One Health approach is a paradigm that has been advanced for more than 30 years, but due to the inadequacy of local and world health policies, this approach was never translated into concrete actions to protect health, feeding problems at the cause of the COVID-19 pandemic.

Conclusions: Having ascertained that the adoption of a One Health approach can no longer be postponed, this must be insisted on several interconnected sectors that establish the new concept of healthcare which, in addition to being interdisciplinary, necessarily takes on a global perspective.

背景:2019冠状病毒病大流行是一场全球地震,有必要对旨在加强共同治理的卫生政策进行审查。目的:本文分析了“同一个健康”方针成为控制流行病现象的根本原因,论证了不仅要将其作为卫生政策的基础,而且要将其作为部门间政策的基础。方法:对疫情前后发表的世界组织文件进行分析研究,揭示新的生活方式与健康风险增加之间的密切关系。结果表明,“同一个健康”方法是一个已经提出了30多年的范例,但由于地方和世界卫生政策的不足,这一方法从未转化为保护健康的具体行动,从而导致COVID-19大流行的问题。结论:在确定不能再推迟采用“同一个健康”方针之后,必须坚持在几个相互联系的部门建立新的保健概念,这种概念除了跨学科之外,还必须具有全球视角。
{"title":"Considerations on the sidelines of the second principle of the Rome Declaration: The challenge of the One Health concept on the health of the future.","authors":"Tommaso Di Paolo","doi":"10.3233/JRS-227003","DOIUrl":"https://doi.org/10.3233/JRS-227003","url":null,"abstract":"<p><strong>Background: </strong>The COVID-19 pandemic represented a global earthquake that made the review of health policies aimed at strengthening common governance necessary.</p><p><strong>Objective: </strong>The paper analyses the reasons for which the One Health approach has become fundamental in the control of pandemic phenomena, by arguing the necessity to place it at the basis not only of health policies but also of intersectoral policies.</p><p><strong>Methods: </strong>The documents of the world organizations published before and after the pandemic were analyzed and studied in order to unpack the close relationship between new lifestyles and the increase of health risks.</p><p><strong>Results: </strong>It emerged that the One Health approach is a paradigm that has been advanced for more than 30 years, but due to the inadequacy of local and world health policies, this approach was never translated into concrete actions to protect health, feeding problems at the cause of the COVID-19 pandemic.</p><p><strong>Conclusions: </strong>Having ascertained that the adoption of a One Health approach can no longer be postponed, this must be insisted on several interconnected sectors that establish the new concept of healthcare which, in addition to being interdisciplinary, necessarily takes on a global perspective.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39910016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Beyond the garden: The complexity of "global and individual living" at the heart of the international commitment towards a healthy, more resilient and fairer society. 花园之外:“全球和个人生活”的复杂性是建立一个健康、更有弹性和更公平的社会的国际承诺的核心。
IF 1.7 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.3233/JRS-227004
Luca Dimasi

Background: The right to fully enjoy the highest possible state of health is certainly nothing new in the agenda of the world's governments, and yet today it becomes a top priority not just in the restructuring of the health care system, but also in the promotion of multi-sector policies aimed at fostering and safeguarding the potential of every individual to achieve what could be defined, in general terms, as "common good".

Objective: The current paper aimed at singling out the most useful strategies to promoting and achieving a healthy, more resilient and fairer society.

Methods: Starting from principles 1 and 14 of the Declaration of Rome, the aim was to analyse and develop the concepts of resilience and health, questioning their possible future variations against the background of the current health emergency and the increasingly radical widespread use of new technologies as universally-applied and cross-sectional tools for human progress.

Results: The "health for all" objective can only be achieved if we act on three key aspects: 1. Adding life to years; 2. Adding life to life; 3. Adding years to life.

Conclusions: Each individual should raise their health awareness as a key resource to leading a fulfilling existence and to developing the required qualities to fully tap into health possibilities - whether integral or residual - to tackle life.

背景:在世界各国政府的议程中,充分享有尽可能高的健康状态的权利当然不是什么新鲜事,但今天,它不仅成为卫生保健系统结构调整的重中之重,而且成为促进多部门政策的重中之重,这些政策旨在培养和保障每个人实现一般意义上可定义为“共同利益”的潜力。目标:本文件旨在挑出促进和实现一个健康、更有弹性和更公平的社会的最有用战略。方法:从《罗马宣言》原则1和原则14出发,目的是分析和发展复原力和健康的概念,在当前突发卫生事件和新技术作为人类进步的普遍应用和横截面工具日益激进广泛使用的背景下,质疑它们未来可能发生的变化。结果:只有在三个关键方面采取行动,才能实现"人人享有卫生保健"的目标:给岁月增添生命;2. 为生命增添生命;3.延长寿命。结论:每个人都应该提高他们的健康意识,把它作为一种重要的资源来引导一个充实的存在,并发展必要的素质,以充分利用健康的可能性——无论是整体的还是剩余的——来应对生活。
{"title":"Beyond the garden: The complexity of \"global and individual living\" at the heart of the international commitment towards a healthy, more resilient and fairer society.","authors":"Luca Dimasi","doi":"10.3233/JRS-227004","DOIUrl":"https://doi.org/10.3233/JRS-227004","url":null,"abstract":"<p><strong>Background: </strong>The right to fully enjoy the highest possible state of health is certainly nothing new in the agenda of the world's governments, and yet today it becomes a top priority not just in the restructuring of the health care system, but also in the promotion of multi-sector policies aimed at fostering and safeguarding the potential of every individual to achieve what could be defined, in general terms, as \"common good\".</p><p><strong>Objective: </strong>The current paper aimed at singling out the most useful strategies to promoting and achieving a healthy, more resilient and fairer society.</p><p><strong>Methods: </strong>Starting from principles 1 and 14 of the Declaration of Rome, the aim was to analyse and develop the concepts of resilience and health, questioning their possible future variations against the background of the current health emergency and the increasingly radical widespread use of new technologies as universally-applied and cross-sectional tools for human progress.</p><p><strong>Results: </strong>The \"health for all\" objective can only be achieved if we act on three key aspects: 1. Adding life to years; 2. Adding life to life; 3. Adding years to life.</p><p><strong>Conclusions: </strong>Each individual should raise their health awareness as a key resource to leading a fulfilling existence and to developing the required qualities to fully tap into health possibilities - whether integral or residual - to tackle life.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39910017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obesity and immune system impairment: A global problem during the COVID-19 pandemic. 肥胖和免疫系统损伤:COVID-19大流行期间的一个全球性问题。
IF 1.7 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.3233/JRS-227007
Rosa Manca, Francisco Bombillar, Chester Glomski, Alessandra Pica

Background: The production of healthy and nutritious food, in an ecologically sustainable and safe way, has become one of the great ethical issues of our time. The recent G 20 urged the "promotion and work on the social determinants of health to address other critical health issues such as food and nutrition".

Objective: The aim of this work is to analyze the current scientific literature regarding the role of obesity in the severe COVID-19 outcomes. In the light of the indications of the G20, the main causes of obesity are examined, and lifestyles are suggested with particular regard to proper nutrition in order to prevent/treat overweight since childhood.

Methods: Multidisciplinary work, in which the biological and legal perspectives provide a meta-legal analysis of the obesity problem.

Results: Unhealthy habits induce metabolic imbalance and increase in the body weight promoting obesity. This condition is the result of many factors (genetic predisposition, social position and "junk food" consumption) and is associated with a high risk of diseases, among them exacerbations from viral respiratory infections, including the current COVID-19 pandemic.

Conclusions: The industrial food revolution changed our eating habits, leading to production of too much unhealthy food, absent in ancient diet, thus contributing to the onset of some disorders. The business of food industry should be downsized in favor of morally or ethically fair choices for consumers and for the well-being of society, together with an ethical food distribution, governmental food education programs, and balanced oversight of food production.

背景:以生态可持续和安全的方式生产健康和营养的食品已成为我们这个时代的重大伦理问题之一。最近的20国集团敦促“促进和努力解决健康的社会决定因素,以解决食品和营养等其他关键健康问题”。目的:本研究的目的是分析目前关于肥胖在COVID-19严重结局中的作用的科学文献。根据二十国集团的指示,研究了肥胖的主要原因,并建议了生活方式,特别是关于适当的营养,以预防/治疗儿童时期的超重。方法:多学科合作,从生物学和法律角度对肥胖问题进行元法律分析。结果:不良生活习惯导致代谢失衡,体重增加,促进肥胖。这种情况是许多因素(遗传易感性、社会地位和“垃圾食品”消费)的结果,并与疾病的高风险有关,其中包括病毒性呼吸道感染的加剧,包括当前的COVID-19大流行。结论:工业食品革命改变了我们的饮食习惯,导致生产了太多不健康的食品,而这些食品在古代饮食中是不存在的,从而导致了一些疾病的发生。为了消费者和社会的福祉,在道德上或伦理上公平的选择,以及合乎道德的食品分配、政府食品教育计划和对食品生产的平衡监督,食品行业应该缩小规模。
{"title":"Obesity and immune system impairment: A global problem during the COVID-19 pandemic.","authors":"Rosa Manca,&nbsp;Francisco Bombillar,&nbsp;Chester Glomski,&nbsp;Alessandra Pica","doi":"10.3233/JRS-227007","DOIUrl":"https://doi.org/10.3233/JRS-227007","url":null,"abstract":"<p><strong>Background: </strong>The production of healthy and nutritious food, in an ecologically sustainable and safe way, has become one of the great ethical issues of our time. The recent G 20 urged the \"promotion and work on the social determinants of health to address other critical health issues such as food and nutrition\".</p><p><strong>Objective: </strong>The aim of this work is to analyze the current scientific literature regarding the role of obesity in the severe COVID-19 outcomes. In the light of the indications of the G20, the main causes of obesity are examined, and lifestyles are suggested with particular regard to proper nutrition in order to prevent/treat overweight since childhood.</p><p><strong>Methods: </strong>Multidisciplinary work, in which the biological and legal perspectives provide a meta-legal analysis of the obesity problem.</p><p><strong>Results: </strong>Unhealthy habits induce metabolic imbalance and increase in the body weight promoting obesity. This condition is the result of many factors (genetic predisposition, social position and \"junk food\" consumption) and is associated with a high risk of diseases, among them exacerbations from viral respiratory infections, including the current COVID-19 pandemic.</p><p><strong>Conclusions: </strong>The industrial food revolution changed our eating habits, leading to production of too much unhealthy food, absent in ancient diet, thus contributing to the onset of some disorders. The business of food industry should be downsized in favor of morally or ethically fair choices for consumers and for the well-being of society, together with an ethical food distribution, governmental food education programs, and balanced oversight of food production.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39910020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Non-steroidal anti-inflammatory drugs and risk of acute adverse renal outcomes in diabetes and diabetic kidney disease. 非甾体抗炎药与糖尿病和糖尿病肾病急性不良肾脏结局的风险
IF 1.7 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.3233/JRS-200096
Cynthia Ciwei Lim, Hanis Bte Abdul Kadir, Ngiap Chuan Tan, Andrew Teck Wee Ang, Yong Mong Bee, Puay Hoon Lee, Bandy Qiuling Goh, Alcey Li Chang Ang, Xiaohui Xin, Jia Liang Kwek, Amanda Yun Rui Lam, Jason Chon Jun Choo

Background: Individuals with diabetes mellitus (DM) may be susceptible to non-steroidal anti-inflammatory drug (NSAID)-induced acute kidney injury (AKI) but data on NSAID-related adverse renal events is sparse.

Objective: We aimed to evaluate the risk of acute kidney injury and/or hyperkalemia after systemic NSAID among individuals with DM and diabetic chronic kidney disease (CKD).

Methods: Retrospective cohort study of 3896 adults with DM with incident prescriptions between July 2015 and December 2017 from Singapore General Hospital and SingHealth Polyclinics. Laboratory, hospitalization and medication data were retrieved from electronic medical records. The primary outcome was the incidence of AKI and/ or hyperkalemia within 30 days after prescription.

Results: AKI and/or hyperkalemia occurred in 13.5% of all DM and 15.8% of diabetic CKD. The association between systemic NSAID >14 days and 30-day risk of AKI and/or hyperkalemia failed to reach statistical significance in unselected DM (adjusted OR 1.62, 95% CI 0.99-2.65, p = 0.05) and diabetic CKD (adjusted OR 0.64, 95% CI 0.15-2.82, p = 0.64), but the odds of AKI and/or hyperkalemia were markedly and significantly increased when NSAID was prescribed with renin-angiotensin-aldosterone system (RAAS) blocker (adjusted OR 4.17, 95% CI 1.74-9.98, p = 0.001) or diuretic (adjusted OR 3.31, 95% CI 1.09-10.08, p = 0.04) and in the absence of diabetic CKD (adjusted OR 1.98, 95% CI 1.16-3.36, p = 0.01).

Conclusion: NSAID prescription >14 days in individuals with DM with concurrent RAAS blockers or diuretics was associated with higher 30-day risk of AKI and/or hyperkalemia.

背景:糖尿病(DM)患者可能容易发生非甾体抗炎药(NSAID)诱导的急性肾损伤(AKI),但有关非甾体抗炎药相关的肾脏不良事件的数据很少。目的:我们旨在评估糖尿病和糖尿病性慢性肾脏疾病(CKD)患者全身性非甾体抗炎药(NSAID)后急性肾损伤和/或高钾血症的风险。方法:回顾性队列研究2015年7月至2017年12月来自新加坡总医院和新加坡卫生综合诊所的3896名成人糖尿病患者的事件处方。从电子病历中检索实验室、住院和用药数据。主要终点是处方后30天内AKI和/或高钾血症的发生率。结果:AKI和/或高钾血症发生在13.5%的DM和15.8%的糖尿病性CKD中。非选择性糖尿病患者(调整or 1.62, 95% CI 0.99-2.65, p = 0.05)和糖尿病性CKD患者(调整or 0.64, 95% CI 0.15-2.82, p = 0.64),全体性非甾体抗炎药>14天与30天AKI和/或高钾血症风险之间的相关性未达到统计学意义,但当非甾体抗炎药与肾素-血管紧张素-醛固酮系统(RAAS)阻滞剂联合使用时,AKI和/或高钾血症的发生率显著增加(调整or 4.17, 95% CI 1.74-9.98,p = 0.001)或利尿剂(调整后的or为3.31,95% CI为1.09-10.08,p = 0.04)和无糖尿病性CKD(调整后的or为1.98,95% CI为1.16-3.36,p = 0.01)。结论:非甾体抗炎药处方>14天的糖尿病患者同时服用RAAS阻滞剂或利尿剂,其30天AKI和/或高钾血症的风险较高。
{"title":"Non-steroidal anti-inflammatory drugs and risk of acute adverse renal outcomes in diabetes and diabetic kidney disease.","authors":"Cynthia Ciwei Lim,&nbsp;Hanis Bte Abdul Kadir,&nbsp;Ngiap Chuan Tan,&nbsp;Andrew Teck Wee Ang,&nbsp;Yong Mong Bee,&nbsp;Puay Hoon Lee,&nbsp;Bandy Qiuling Goh,&nbsp;Alcey Li Chang Ang,&nbsp;Xiaohui Xin,&nbsp;Jia Liang Kwek,&nbsp;Amanda Yun Rui Lam,&nbsp;Jason Chon Jun Choo","doi":"10.3233/JRS-200096","DOIUrl":"https://doi.org/10.3233/JRS-200096","url":null,"abstract":"<p><strong>Background: </strong>Individuals with diabetes mellitus (DM) may be susceptible to non-steroidal anti-inflammatory drug (NSAID)-induced acute kidney injury (AKI) but data on NSAID-related adverse renal events is sparse.</p><p><strong>Objective: </strong>We aimed to evaluate the risk of acute kidney injury and/or hyperkalemia after systemic NSAID among individuals with DM and diabetic chronic kidney disease (CKD).</p><p><strong>Methods: </strong>Retrospective cohort study of 3896 adults with DM with incident prescriptions between July 2015 and December 2017 from Singapore General Hospital and SingHealth Polyclinics. Laboratory, hospitalization and medication data were retrieved from electronic medical records. The primary outcome was the incidence of AKI and/ or hyperkalemia within 30 days after prescription.</p><p><strong>Results: </strong>AKI and/or hyperkalemia occurred in 13.5% of all DM and 15.8% of diabetic CKD. The association between systemic NSAID >14 days and 30-day risk of AKI and/or hyperkalemia failed to reach statistical significance in unselected DM (adjusted OR 1.62, 95% CI 0.99-2.65, p = 0.05) and diabetic CKD (adjusted OR 0.64, 95% CI 0.15-2.82, p = 0.64), but the odds of AKI and/or hyperkalemia were markedly and significantly increased when NSAID was prescribed with renin-angiotensin-aldosterone system (RAAS) blocker (adjusted OR 4.17, 95% CI 1.74-9.98, p = 0.001) or diuretic (adjusted OR 3.31, 95% CI 1.09-10.08, p = 0.04) and in the absence of diabetic CKD (adjusted OR 1.98, 95% CI 1.16-3.36, p = 0.01).</p><p><strong>Conclusion: </strong>NSAID prescription >14 days in individuals with DM with concurrent RAAS blockers or diuretics was associated with higher 30-day risk of AKI and/or hyperkalemia.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39315525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Antibiotic misuse and improper practices in India: Identifying the scope to improve through a narrative review. 印度抗生素滥用和不当做法:通过叙述性审查确定需要改进的范围。
IF 1.7 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.3233/JRS-210020
Brinal Pereira, Shruti Kulkarni

Background: In India, antibiotic resistance is high and by 2050, two million people will be affected.

Objective: To review antibiotic practices in India and the variables that impact them.

Methods: For this narrative review, research articles on antibiotic awareness, perception and practices were retrieved from PubMed and Google Scholar using search terms such as 'India AND antibiotic use AND cross sectional AND awareness'. A total of 1730 results were found on 30 June 2020, of which 35 articles were eligible for summarizing the common antibiotic practices.

Results: We found that there are deficiencies in the implementation of existing policies in India. Several issues such as overprescribing of antibiotics, use without prescription and non-adherence to treatment regimens are contributing to irrational antibiotic practices in the country.

Conclusion: There is a need for policies at the institute level to help curb the problem of antibiotic resistance.

背景:在印度,抗生素耐药性很高,到2050年,将有200万人受到影响。目的:回顾抗生素在印度的做法和影响他们的变量。方法:在这篇叙述性综述中,使用“印度和抗生素使用以及横截面和意识”等搜索词,从PubMed和Google Scholar检索了关于抗生素意识、感知和实践的研究文章。截至2020年6月30日,共发现1730篇结果,其中35篇符合总结常用抗生素做法的条件。结果:我们发现印度现有政策的执行存在不足。抗生素处方过度、无处方使用和不遵守治疗方案等若干问题助长了该国不合理的抗生素做法。结论:有必要在机构层面制定政策,帮助遏制抗生素耐药性问题。
{"title":"Antibiotic misuse and improper practices in India: Identifying the scope to improve through a narrative review.","authors":"Brinal Pereira,&nbsp;Shruti Kulkarni","doi":"10.3233/JRS-210020","DOIUrl":"https://doi.org/10.3233/JRS-210020","url":null,"abstract":"<p><strong>Background: </strong>In India, antibiotic resistance is high and by 2050, two million people will be affected.</p><p><strong>Objective: </strong>To review antibiotic practices in India and the variables that impact them.</p><p><strong>Methods: </strong>For this narrative review, research articles on antibiotic awareness, perception and practices were retrieved from PubMed and Google Scholar using search terms such as 'India AND antibiotic use AND cross sectional AND awareness'. A total of 1730 results were found on 30 June 2020, of which 35 articles were eligible for summarizing the common antibiotic practices.</p><p><strong>Results: </strong>We found that there are deficiencies in the implementation of existing policies in India. Several issues such as overprescribing of antibiotics, use without prescription and non-adherence to treatment regimens are contributing to irrational antibiotic practices in the country.</p><p><strong>Conclusion: </strong>There is a need for policies at the institute level to help curb the problem of antibiotic resistance.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39614950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Improving communication at NHS Nightingale Hospital North West: Medical updates to next of kin. 改善NHS南丁格尔医院西北的沟通:向近亲提供医疗更新。
IF 1.7 Q3 Medicine Pub Date : 2022-01-01 DOI: 10.3233/JRS-227034
Megan Woolford, James Todd

Background: The Nightingale North West (NNW) was a UK temporary field hospital set up during the COVID-19 pandemic. Policies and standard operating procedures were undeveloped. Visitors were permitted only in exceptional circumstances, resulting in heightened anxiety for patients and next of kin (NOK).

Objective: Recognising the importance of effective NOK communication, a quality improvement project (QIP) was undertaken to improve communication between doctors and NOK.

Method: NOK satisfaction with communication received from doctors (scored 1-5) was the primary outcome measure and data was collected through standardised phone-calls.A wide four point (1-5) variability in satisfaction was identified.PDSA methodology was used to introduce interventions: (1) 'Gold standard' for frequency of NOK updates; (2) Record date of NOK update on the doctors' list.

Results: Early post-intervention data showed reduced variability in satisfaction with 82% of NOK scoring '4' or '5'. Process measures demonstrated excellent uptake of interventions.

Conclusion: Conclusions are limited by the project's short time-frame but there is a promising role for these interventions in enhancing doctor-NOK communication.

背景:南丁格尔西北医院(NNW)是英国在COVID-19大流行期间建立的临时野战医院。政策和标准操作程序尚未制定。只有在特殊情况下才允许访客,这导致患者和近亲(NOK)的焦虑加剧。目的:认识到NOK有效沟通的重要性,开展质量改进项目(QIP)以改善医生与NOK之间的沟通。方法:NOK对医生沟通的满意度(1-5分)为主要评价指标,通过标准化电话收集数据。满意度有4点(1-5)的差异。采用PDSA方法引入干预措施:(1)NOK更新频率的“黄金标准”;(2)在医生名单上记录NOK更新日期。结果:早期干预后数据显示满意度的可变性降低,82%的NOK评分为“4”或“5”。过程测量显示了对干预措施的良好吸收。结论:结论受到项目时间短的限制,但这些干预措施在加强医生与nok的沟通方面有很好的作用。
{"title":"Improving communication at NHS Nightingale Hospital North West: Medical updates to next of kin.","authors":"Megan Woolford,&nbsp;James Todd","doi":"10.3233/JRS-227034","DOIUrl":"https://doi.org/10.3233/JRS-227034","url":null,"abstract":"<p><strong>Background: </strong>The Nightingale North West (NNW) was a UK temporary field hospital set up during the COVID-19 pandemic. Policies and standard operating procedures were undeveloped. Visitors were permitted only in exceptional circumstances, resulting in heightened anxiety for patients and next of kin (NOK).</p><p><strong>Objective: </strong>Recognising the importance of effective NOK communication, a quality improvement project (QIP) was undertaken to improve communication between doctors and NOK.</p><p><strong>Method: </strong>NOK satisfaction with communication received from doctors (scored 1-5) was the primary outcome measure and data was collected through standardised phone-calls.A wide four point (1-5) variability in satisfaction was identified.PDSA methodology was used to introduce interventions: (1) 'Gold standard' for frequency of NOK updates; (2) Record date of NOK update on the doctors' list.</p><p><strong>Results: </strong>Early post-intervention data showed reduced variability in satisfaction with 82% of NOK scoring '4' or '5'. Process measures demonstrated excellent uptake of interventions.</p><p><strong>Conclusion: </strong>Conclusions are limited by the project's short time-frame but there is a promising role for these interventions in enhancing doctor-NOK communication.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7a/46/jrs-33-jrs227034.PMC9844058.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10782290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1